{"id":2195,"date":"2021-12-21T08:00:56","date_gmt":"2021-12-21T08:00:56","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=2195"},"modified":"2021-12-22T10:55:45","modified_gmt":"2021-12-22T10:55:45","slug":"medoject-hypodermic-and-blunt-fill-needles","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","title":{"rendered":"Medoject hypodermic and blunt fill needles"},"content":{"rendered":"

An update has recently been issued by the MHRA (Medicines and Healthcare products Regulatory Agency) warning of the potential dangers of Medoject hypodermic and blunt fill needles produced by the manufacturer. After concerns were raised about certain batches, the manufacturer issued a Field Safety Notice recalling the five batches of needles in question, according to the MHRA<\/strong><\/a>. Used by healthcare services across the UK, there is a worry that a potentially harmful substance may have been unknowingly injected into patients.<\/p>\n

Over the years, we have taken on a number of claims regarding faulty or harmful medical products, including hernia mesh and metal-on-metal hip implants. One of our biggest group litigation cases is that of the PIP breast implants – in our action, we have already recovered over \u00a31m in compensation for the victims.<\/p>\n

Although there is currently no evidence to suggest that anyone has been harmed by the Medoject needles, we believe that all cases like these require thorough investigation.<\/p>\n

<\/p>\n

The issue of the Medoject hypodermic and blunt fill needles<\/strong><\/h3>\n

Users of the Medoject hypodermic and blunt fill needles have recently noticed black residues that are reportedly on the outside of the product, according to the MHRA<\/strong><\/a>. Following the issuance of a Field Safety Notice, the five relevant batches have been recalled based on reports by users.<\/p>\n

The MHRA investigated the issue, but has been unable to find the cause of issues raised thus far. The regulator has stated that all batches may be affected and more may, therefore, need to be recalled in future.<\/p>\n

The nature of the black substance was established following the Field Safety Notice, revealing that it is amorphous carbon. The manufacturer has stated that there is only a minimal risk of harm to patients, but there is still cause for concern given that the cause of the issue is unknown. Indeed, if the manufacturer cannot establish how the amorphous carbon came to be on the Medoject hypodermic and blunt fill needles, it means they are unable to rule out the possibility of this happening again, or happening with another substance.<\/p>\n

The MHRA\u2019s advice<\/strong><\/h3>\n

The MHRA advised that all Medoject hypodermic and blunt fill needles need to be identified by healthcare professionals, then removed and disposed of. Healthcare professionals should share information with users of the products, and report any adverse impacts of the device according to appropriate procedure.<\/p>\n

Claiming compensation for a harmful medical product<\/strong><\/h3>\n

Poor regulation and negligence from medical practitioners can sometimes lead to patients using potentially harmful medical devices. In some cases, the blame can lie primarily with a manufacturer for failing to properly review potential dangers, or in other cases, the doctors themselves can be at fault for wrongfully advising the patient to use a medical product.<\/p>\n

In either case, it may be possible to bring compensation claims in order to achieve justice. In a claim, we may be able to recover compensation for any pain, suffering and loss of amenity caused by the product, and for any financial losses or expenses which may have been incurred as a result.<\/p>\n

With our group action experience, we are accustomed to holding huge companies to account for their negligent actions. It can be tricky to establish liability in medical product cases, but we have the specialist knowledge to do this effectively.<\/p>\n

Hopefully, there will be no problems for patients involved in this issue, and that will be the end of things.<\/p>\n

To find out more about making a potential compensation claim, contact our team today for free, no-obligation advice on your case.<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

An update has recently been issued by the MHRA (Medicines and Healthcare products Regulatory Agency) warning of the potential dangers of Medoject hypodermic and blunt fill needles produced by the manufacturer. After concerns were raised about certain batches, the manufacturer issued a Field Safety Notice recalling the five batches of needles in question, according to … Continue reading Medoject hypodermic and blunt fill needles<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1350,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[80,1,5,27,10],"tags":[14,25,81,58,60,61,20,11,55,8],"class_list":["post-2195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-group-actions","category-latest","category-medical","category-products","category-recalls","tag-class-actions","tag-device-alerts","tag-group-action","tag-medical-devices","tag-medical-product","tag-medical-recall","tag-mhra","tag-news","tag-product-safety","tag-recalls"],"yoast_head":"\nMedoject hypodermic and blunt fill needles - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medoject hypodermic and blunt fill needles - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-21T08:00:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-22T10:55:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png\" \/>\n\t<meta property=\"og:image:width\" content=\"725\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Medoject hypodermic and blunt fill needles\",\"datePublished\":\"2021-12-21T08:00:56+00:00\",\"dateModified\":\"2021-12-22T10:55:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles\"},\"wordCount\":596,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1\",\"keywords\":[\"class actions\",\"device alerts\",\"group action\",\"medical devices\",\"medical product\",\"medical recall\",\"mhra\",\"news\",\"product safety\",\"recalls\"],\"articleSection\":[\"Group Actions\",\"Latest\",\"Medical\",\"Products\",\"Recalls\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles\",\"name\":\"Medoject hypodermic and blunt fill needles - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2021-12-21T08:00:56+00:00\",\"dateModified\":\"2021-12-22T10:55:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1\",\"width\":725,\"height\":250,\"caption\":\"injection warning\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/medoject-hypodermic-and-blunt-fill-needles#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medoject hypodermic and blunt fill needles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medoject hypodermic and blunt fill needles - Group Action Lawyers","description":"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","og_locale":"en_GB","og_type":"article","og_title":"Medoject hypodermic and blunt fill needles - Group Action Lawyers","og_description":"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","og_site_name":"Group Action Lawyers","article_published_time":"2021-12-21T08:00:56+00:00","article_modified_time":"2021-12-22T10:55:45+00:00","og_image":[{"width":725,"height":250,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Medoject hypodermic and blunt fill needles","datePublished":"2021-12-21T08:00:56+00:00","dateModified":"2021-12-22T10:55:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles"},"wordCount":596,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1","keywords":["class actions","device alerts","group action","medical devices","medical product","medical recall","mhra","news","product safety","recalls"],"articleSection":["Group Actions","Latest","Medical","Products","Recalls"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","name":"Medoject hypodermic and blunt fill needles - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1","datePublished":"2021-12-21T08:00:56+00:00","dateModified":"2021-12-22T10:55:45+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"An update has recently been issued by the MHRA warning of the potential dangers of Medoject hypodermic and blunt fill needles.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1","width":725,"height":250,"caption":"injection warning"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Medoject hypodermic and blunt fill needles"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1","jetpack-related-posts":[{"id":1697,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","url_meta":{"origin":2195,"position":0},"title":"Valsartan recall widens","author":"Author","date":"7th December 2018","format":false,"excerpt":"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA). Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/health"},"img":{"alt_text":"drug recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":1681,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/bone-cement-complications-from-product-recall","url_meta":{"origin":2195,"position":1},"title":"Bone cement complications from product recall","author":"Author","date":"9th November 2018","format":false,"excerpt":"A regulator warning earlier this year stemmed from bone cement complications caused by an issue with the product itself. A risk of the need for revision surgery from the use of Optipac 40 Refobacin Revision and Optipac 80 Refobacin Revision was identified. Manufacturer, Biomet UK Limited, issued a Field Safety\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"medical device recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":2187,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/mhra-raises-alert-regarding-potential-incomplete-sterilisation-steril-milano","url_meta":{"origin":2195,"position":2},"title":"MHRA raises alert regarding potential \u201cincomplete sterilisation\u201d – Steril Milano","author":"Author","date":"7th December 2021","format":false,"excerpt":"The Medicines and Healthcare products Regulatory Agency (MHRA), the UK government regulator that monitors the practices of medical product manufacturers and the safety of the goods they produce, has reportedly identified fraudulent activity involving a company based in Italy. Steril Milano is understood to provide services for sterilising medical equipment\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"hip replacement claims","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/hip-replacement-claims-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/hip-replacement-claims-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/hip-replacement-claims-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/hip-replacement-claims-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1652,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","url_meta":{"origin":2195,"position":3},"title":"Latanoprost Timolol eye drops recall","author":"Author","date":"7th September 2018","format":false,"excerpt":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA). The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an \u2018out of specification result for an unknown impurity\u2019 that was identified during testing.\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"eye claims","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":2195,"position":4},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3187,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","url_meta":{"origin":2195,"position":5},"title":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall","author":"Author","date":"28th October 2025","format":false,"excerpt":"A recall of Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA. The Group Action Lawyers specialises\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"incorrect dose content statement","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=2195"}],"version-history":[{"count":2,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2195\/revisions"}],"predecessor-version":[{"id":2248,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2195\/revisions\/2248"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/1350"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=2195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=2195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=2195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}